Background: Lymphangioleiomyomatosis (LAM) is a rare disease involving the bronchi, lymphatic vessels, and veins. However, there are few reports about lymphatic vessel abnormalities associated with LAM. Purpose: To evaluate computed tomography (CT) lymphangiography findings in cases of LAM, especially lymphatic vessel abnormalities. Material and Methods: Twenty-seven patients with LAM underwent direct lymphangiography (DLG), followed by a post-procedural thoracoabdominal CT examination. Results: All 27 patients were diagnosed with LAM, including 25 (93%) with chylothorax, eight (30%) with chyloperitoneum, seven (26%) with chylous fluid in the chest and abdomen, and one (4%) with lower-limb lymphedema. The CT lymphangiography showed that 27/27 (100%) patients presented iliac or retroperitoneal lymphatic vessel dilation; 20/27 (74%) presented thoracic duct outlet obstruction; 9/27 (33%) presented pleural lymph leakage; and 13/27 (48%) presented an abnormal distribution of contrast agent in the contralateral lumbar trunk, 3/27 (11%) in the pulmonary field, 1/27 (4%) in the abdominal cavity, and 4/27 (15%) in the pelvic cavity. Five of the 27 patients (19%) had retroperitoneal lymphangioleiomyomas, with contrast agent accumulation in three cases during CT lymphangiography. Two of the 27 (7%) patients had enlarged lymph nodes in the retroperitoneum. All 27 patients (100%) diagnosed with LAM displayed various lung cysts on thoracic high-resolution CT scans. Conclusion: CT lymphangiography findings can be used to diagnose most LAM cases accurately. Moreover, these findings also display the various lymphatic vessel abnormalities associated with LAM.
Introduction
Lymphangioleiomyomatosis (LAM) is a rare multisystem disorder characterized by cystic lung destruction that primarily affects women of child-bearing age (1) . Most LAMs are sporadic, but they can also occur due to a genetic condition called tuberous sclerosis complex (TSC) (2) . LAM predominantly affects the lungs, but can also occur along the axial lymphatic system, including the lymph nodes in the mediastinum, retroperitoneum, pelvic cavity, and thoracic duct. The clinical manifestations of LAM include exertional dyspnea, spontaneous pneumothorax, hemosputum, chylous pleural effusion, and symptoms associated with extrapulmonary involvement (3) . Extrapulmonary manifestations, which may occur in more than 70% of patients, include angiomyolipomas (AMLs), lymphadenopathy, lymphangioleiomyomas, chylous ascites, and pleural effusions (4) . The presence of LAM cells, which are abnormal-appearing, smooth muscle-like cells, is the hallmark characteristic of LAM (5) . Abnormality of the TSC1 or TSC2 tumor suppressor gene plays an important role in the transformation of LAM cells (6) . Since the first report of LAM by Cornog and Enterline in 1966 (7) , there has been increasing interest in the pathological processes involved in the proliferation of atypical smooth muscle LAM cells. Owing to the rarity of this disease, it has been difficult to develop a full understanding of its natural course.
Recently, multiple-slice computed tomography (MSCT) has been extensively applied in LAM cases (8) (9) (10) , such as pulmonary cystic changes, lymphangioleiomyoma, renal angiomyolipoma, and retroperitoneal nodes. The proliferation of LAM cells can obstruct bronchi, veins, and lymphatic vessels (11, 12) . When lymphatic vessels are obstructed or invaded by LAM cells, various chylous reflux or chyle leak diseases occur, such as chylothorax, chyloperitoneum, chyluria, or lymphedema of the limbs. However, abnormalities of the lymph vessels in LAM cases, particularly in the thoracic duct, have only rarely been mentioned (13, 14) . Abnormalities of lymphatic vessels in LAM, however, are closely related to chylous reflux diseases.
Traditional direct lymphangiography (DLG) is reported as a valuable tool for the detection of various lymphatic vessel abnormalities (15) . However, the main limitation of DLG is the two-dimensional (2D) image, which has poor resolution due to image overlapping and thus limits ability to observe lesion details. It is necessary therefore to search for other imaging modalities that can detect lymphatic vessel abnormalities with greater accuracy. Recently, some reports mentioned that post-lymphangiographic CT, i.e. CT lymphangiography is useful for determining the level of lymphatic vessel leakage (16) . Moreover, a recent study also showed that post-lymphangiographic CT allowed users to identify more thoracic duct branches in canines than radiographic lymphangiograms (17) . Therefore, CT lymphangiography can be used to simultaneously observe abnormalities inside and outside of the lymphatic system. The purpose of this study was to evaluate CT lymphangiography findings, specifically the detection of lymphatic vessel abnormalities, in 27 patients diagnosed with LAM.
Material and Methods Patients
This study was approved by our institutional review board. Twenty-seven patients (all women; mean age, 39 years; age range, 17-53 years) diagnosed as LAM were recruited in this retrospective study from January 2007 to November 2013. Informed consent was obtained from all patients. Typical symptoms, including chest tightness, progressive dyspnea, and shortness of breath, were demonstrated in 25 of the 27 patients, while abdominal pain and distention were shown in one patient and lowerlimb lymphedema in another patient. Furthermore, all patients had common signs of various chylous reflux diseases. All patients underwent DLG and post-procedural non-enhanced CT examination.
Of the 27 patients with LAM, 17 were pathologically confirmed and 10 were diagnosed as LAM according to the European guidelines for LAM before or after lymphangiography (18) . Seventeen cases were histologically diagnosed by reviewing tissue specimens from: (i) an open lung biopsy in five patients; (ii) a lymph node resection in two patients; (iii) a thoracic duct resection in four patients; (iv) a retroperitoneal lymphangioleiomyoma resection in five patients; and (v) a kidney AML and an ovary teratoma resection in one patient.
DLG and CT lymphangiography
One milliliter of methylene blue and 2% lidocaine mixed liquor (1:1) was injected subcutaneously into the foot of the asymptomatic side. Subsequently, 1% lidocaine was injected into the central mid-portion of the acrotarsium for local anesthesia. A 1-cm incision was made across the skin, and one blue-stained superficial lymphatic vessel was identified. The lumen of this vessel was punctured with a 30-gauge needle and then an intralymphatic injection of iodipin (Lipiodol; Laboratoire Guerbet, Roissy, France) was injected using an intravenous pump. A normal dose of 8-15 mL of iodipin was injected into the lymphatic vessel of each extremity. The rate of injection was 6-8 mL/h, depending on the size of the lymphatic vessel. One lymphatic surgeon with 10 years of experience performed all procedures.
After the injection of the contrast agent, CT was acquired from the lower limbs to the cervical region, including the pelvis, abdomen, chest, and jugular venous angulus. CT lymphangiography (CTL) was performed just immediately after the DLG within 60 min. Non-contrast CTL was performed using a 16-slice scanner (SOMATOM Sensation, Siemens Medical Healthcare, Forchheim, Germany) or a 256-slice scanner (Brilliance iCT, Philips Medical Healthcare, Best, The Netherlands) and the scanning ranged from the thoracic apex to the bottom. The Siemens scanner was used to obtain an 8-mm thick section and an image with a slice thickness of 2 mm is featured. The Philips scanner produced scans of 0.9 mm thickness, and then 2 mm and 8 mm images were reconstructed.
Images of the chest were obtained at the end of inspiration with the patients in the supine position using a 5-10 mm collimation. Then, the CT images were transferred to Workspace. High-resolution CT (HRCT) images of the lung were reconstructed from the helical data in all cases. All 27 patients were examined successfully in both CTL and DLG, and all images were reviewed by two radiologists with >5 years of experience in thoracic and abdominal diseases. Lymphatic vessel abnormalities were evaluated, including thoracic duct outlet obstruction, iliac lymphatic vessel and lumbar trunk dilation, pleural and abdominal lymph leakage, and some extralymphatic abnormalities, and a consensus was made after discussion when required.
Results

Chylous reflux diseases associated with LAM
A total of 27 patients were diagnosed with LAM, and 25/27 (93%) had unilateral or bilateral chylothorax, 8/27 (30%) had chyloperitoneum, 7/27 (26%) had chylous fluid in the chest and abdomen, and 1/27 (4%) had lower-limb lymphedema ( Table 1) .
The presence of chylothorax or chyloperitoneum was defined by one or more of the following inclusion criteria: (i) a pleural fluid or an ascites triglyceride level of 110 mg/dL or greater; and (ii) the presence of chylomicrons in pleural effusions or ascites.
CT lymphangiography showed various degrees of abnormal lymphatic system manifestations in all 27 patients diagnosed with LAM ( Twenty thoracic duct outlet obstructions showed widening, tortuosity, or disorder at the end of the thoracic duct on CT lymphangiography, with sizes in the range of 0.4-1.2 cm.
The size ranges for the dilation of the thoracic segment of the thoracic duct, the iliac lymphatic vessel and lumbar trunk, and the intrapulmonary lymphatic vessels were 0.3-0.6 cm, 0.5-1.8 cm, and 0.1-0.4 cm, respectively.
Pleural lymph leakage showed iodipin accumulation in the pleural cavity on the CT lymphangiography. Five of the nine pleural lymph leakages had a nodular appearance, while the other four had a beaded appearance.
Abnormal pelvic distribution of the contrast agent meant that there was iodipin accumulation surrounding the uterus, rectum, and bladder, or that there was iodipin deposition in the wall of the rectum and the pelvic spatium intermusculare.
The CT lymphangiography displayed retroperitoneal lymphangioleiomyomas surrounding the aorta and inferior vena cava in 5/27 (19%) patients, of which three had contrast agent accumulation in the thick or thin walls (Fig. 2c ). Two of 27 (7%) presented enlarged lymph nodes in the retroperitoneum surrounding the aorta and inferior vena cava, with a clear margin and sizes in the range of 5-15 mm. Both of the lymphangioleiomyomas and enlarged lymph nodes were confirmed by pathology.
Extralymphatic system abnormality
To date, cysts have been observed in 100% of patients with LAM, including all 27 cases in this study (Fig. 3b ). Such cysts are characteristically round and thin-walled. Nevertheless, some also have an irregular configuration. The sizes of the pulmonary cysts were in the range of 2-15 mm, with amounts ranging from few to whole lung involvement. Nephritic angiomyolipoma and ovarian teratoma were pathologically confirmed in one patient. 
Discussion
According to the European Respiratory Society guidelines (18), a definitive diagnosis of LAM can be made based on the presence of multiple characteristic cysts on lung HRCT and any of the following: kidney angiomyolipoma, thoracic or abdominal chylous effusion, lymphangioleiomyoma or lymph nodes involved in LAM, and either definite or probable TSC. Most patients (26/ 27, 96%) with thoracoabdominal CT lymphangiography findings in this report were diagnosed based on this guideline, making it possible to avoid a tissue biopsy. If these extrapulmonary manifestations of the disease were not evident, a lung biopsy would have been considered to confirm the diagnosis (19) . Radiographic lymphangiography is considered the standard for observation of thoracic duct branches. However, in CT, images can be evaluated without superimposition, and the patient does not need to be repositioned during the scan. Additionally, the scanned helical axial images can be reconstructed into a threedimensional (3D) reformat, which can display the tissue structure outside of the lymphatic vessel. Therefore, CT lymphangiography has a wide range of applications.
Lymphatic system manifestations are present in a substantial fraction of patients with LAM, according to a previous report (20) . The percentage of cases with chylous pleural effusions was 30%, chylous ascites was 10%, and lower extremity lymphedema was 4%. However, in this study, the proportion of cases presenting chylothorax with LAM (25/27, 93%) was higher than that in the previous report. The proportion of cases presenting chyloperitoneum (8/27, 30%) was also higher than in the previous report. The obstruction and damage of lymphatic vessels may be a potential mechanism involved in the development of chylothorax and chyloperitoneum (21) .
Under normal conditions, once iodipin is injected into a superficial lymphatic vessel of the foot, it will be absorbed in the deep lymphatic vessel of the ipsilateral lower limb, and then, it will travel along the ipsilateral iliac lymphatic vessel and lumbar trunk and enter the cisterna chyli, ascending along the thoracic duct and finally collecting in the internal jugular vein at the left infraclavicular region. During this course, iodipin deposition in any other region is defined as abnormal distribution. In this report, 20 of the 27 patients (74%) had a thoracic duct outlet obstruction shown by CT lymphangiography, which revealed widening, tortuosity or disorder in the end of the thoracic duct, with little abnormal iodipin accumulation to the left neck, left subclavian region, and mediastinal region. Clusters of LAM cells infiltrating in the lymphatic vessels may account for the obstruction of the thoracic duct outlet. The abnormal distribution of the contrast agent in the thoracic duct tributaries is due to the extensive pressure caused by the end of the thoracic duct.
Dilation of the thoracic segment of the thoracic duct was found in 12 (44%) cases via CT lymphangiography, and intrapulmonary lymphatic vessel dilation with iodipin accumulation was found in three (11%) cases, which may be due to the extensive pressure caused by the obstruction of the end of the thoracic duct.
Of the 27 patients with LAM, all displayed distortion and dilation of the iliac lymphatic vessel and lumbar trunk of the punctured lateral lumbar trunk, accompanied by iodipin accumulation in the contralateral lumbar trunk. Two causes were considered: the thin walls of the iliac lymphatic vessel and lumbar trunk, and the extensive pressure attributed to the end of the thoracic duct.
Chyle leakage into the body cavities occurs in a subset of LAM patients, owing to the direct invasion or proximal obstruction of the lymphatic system, particularly in the thoracic duct and its tributaries (22) . In this report, CT lymphangiography showed chylous leakage into the pleural cavity in nine cases (33.3%); five had a nodular appearance and four had a beaded appearance. A previous report mentioned that the mean lymph drainage volume before therapeutic lymphangiography in patients with leakage that appeared beaded was higher than in patients with leakage that appeared nodular (23). An abnormal abdominal distribution of contrast agent was also found in one case that showed iodipin accumulation around the hepatic hilum and the head of the pancreas on CT lymphangiography, which may be responsible for the chyloperitoneum associated with LAM. Abnormal iodipin accumulation was also found inside of the right renal fossa, but whether it was related to the resection of the right kidney was unclear. In addition, four cases (15%) of abnormal pelvic distribution were also detected by CT lymphangiography.
Lymphangioleiomyomas on CT scans are well-circumscribed lesions of variable dimensions that appear as thick-or thin-walled lobulated masses with a central fluid rich region. These lesions are most frequently found in the retroperitoneal and mediastinal regions (24) . In this study, all five lymphangioleiomyomas were located in the retroperitoneum surrounding the aorta and the inferior vena cava. Interestingly, iodipin accumulation was found in 3/5 lymphangioleiomyomas. Until now, there has been no report with a similar finding. The potential mechanism of contrast agent accumulation is not clear, but a previous report mentioned that abdominal lymphangioleiomyoma was formed by a collection of chyle in the lymphatic vessels (25) , where it can potentially communicate with the lymphatic system. Two patients with LAM had enlarged lymph nodes in the retroperitoneum surrounding the aorta and inferior vena cava. Lymphangioleiomyomas and enlarged lymph nodes in the retroperitoneum are always asymptomatic, and should be differentiated from a retroperitoneal neurogenic tumor or other malignant tumors, such as lymphomas or metastasized tumors.
Lymphedema is a rare complication of LAM and may be associated with the axial lymphatic involvement of dysfunction rather than severe cystic lung destruction. In our study, one patient (1/27, 4%) without chylothorax had right lower extremity lymphedema. DLG and subsequent CT revealed that her left iliac lymphatic vessels were dilated and had an abnormal contrast agent distribution in the right extremely dilated iliac lymphatic vessels, which was accompanied by thoracic duct outlet obstruction. The patient received lymphaticovenous anastomosis of the right lower limb, and her condition had ultimately stabilized by the three-year follow-up visit.
This study had two limitations. First, it was a retrospective study. Second, the sample size of 27 patients with LAM is small. In the future, we will collect more cases of LAM for further prospective and more detailed studies.
In conclusion, thoracic HRCT constructed from CT lymphangiography detects pulmonary cysts and pleural effusions.
Moreover, thoracoabdominal CT lymphangiography provides important accurate information about lymphatic system abnormalities, such as thoracic duct obstructions and pleural lymph leakage. Thus, thoracoabdominal CT lymphangiography is an accurate examination method and can be an important tool for the diagnosis of LAM and for detecting lymphatic disorders associated with LAM.
